Psyllid ID: psy13496
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 249 | ||||||
| 312381624 | 1243 | hypothetical protein AND_06013 [Anophele | 0.702 | 0.140 | 0.8 | 7e-82 | |
| 340715379 | 1182 | PREDICTED: hypothetical protein LOC10064 | 0.767 | 0.161 | 0.708 | 1e-81 | |
| 157136107 | 872 | camp-specific 3,5-cyclic phosphodiestera | 0.702 | 0.200 | 0.805 | 2e-81 | |
| 328783208 | 1209 | PREDICTED: hypothetical protein LOC41402 | 0.767 | 0.157 | 0.708 | 2e-81 | |
| 380013365 | 1212 | PREDICTED: uncharacterized protein LOC10 | 0.767 | 0.157 | 0.708 | 2e-81 | |
| 350400022 | 1182 | PREDICTED: hypothetical protein LOC10074 | 0.714 | 0.150 | 0.770 | 2e-81 | |
| 170045624 | 821 | c-AMP-specific 3',5'-cyclic phosphodiest | 0.702 | 0.213 | 0.805 | 4e-81 | |
| 383863568 | 1087 | PREDICTED: uncharacterized protein LOC10 | 0.714 | 0.163 | 0.770 | 1e-80 | |
| 345491937 | 1063 | PREDICTED: hypothetical protein LOC10011 | 0.702 | 0.164 | 0.795 | 1e-80 | |
| 158294334 | 934 | AGAP005536-PA [Anopheles gambiae str. PE | 0.702 | 0.187 | 0.788 | 8e-80 |
| >gi|312381624|gb|EFR27332.1| hypothetical protein AND_06013 [Anopheles darlingi] | Back alignment and taxonomy information |
|---|
Score = 309 bits (791), Expect = 7e-82, Method: Compositional matrix adjust.
Identities = 140/175 (80%), Positives = 156/175 (89%)
Query: 29 NTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDITRQQEFLTRFKAYL 88
NTSVLENHHWRSA+GCLLES VAEQ+ IRPELE+QISSLILATDITRQQEF+ RF+ YL
Sbjct: 345 NTSVLENHHWRSAIGCLLESGVAEQVQDIRPELEKQISSLILATDITRQQEFIGRFRDYL 404
Query: 89 DSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLP 148
+LD+ + RHFILQI+LKCADISNPCRPWD+SKKWSQKVCEEFFRQGDYERQLNLP
Sbjct: 405 SRDALDMRNTDHRHFILQISLKCADISNPCRPWDISKKWSQKVCEEFFRQGDYERQLNLP 464
Query: 149 VTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWE 203
VTSLCDR +T++PKIQTGFFKFVV+PL +EWHRFL T LS SMM HLR NQA+WE
Sbjct: 465 VTSLCDRQTTTVPKIQTGFFKFVVTPLMDEWHRFLRTDLSHSMMHHLRYNQAQWE 519
|
Source: Anopheles darlingi Species: Anopheles darlingi Genus: Anopheles Family: Culicidae Order: Diptera Class: Insecta Phylum: Arthropoda Superkingdom: Eukaryota |
| >gi|340715379|ref|XP_003396192.1| PREDICTED: hypothetical protein LOC100648320 [Bombus terrestris] | Back alignment and taxonomy information |
|---|
| >gi|157136107|ref|XP_001663656.1| camp-specific 3,5-cyclic phosphodiesterase [Aedes aegypti] gi|108870039|gb|EAT34264.1| AAEL013473-PA [Aedes aegypti] | Back alignment and taxonomy information |
|---|
| >gi|328783208|ref|XP_397457.4| PREDICTED: hypothetical protein LOC414021 [Apis mellifera] | Back alignment and taxonomy information |
|---|
| >gi|380013365|ref|XP_003690732.1| PREDICTED: uncharacterized protein LOC100869255 [Apis florea] | Back alignment and taxonomy information |
|---|
| >gi|350400022|ref|XP_003485709.1| PREDICTED: hypothetical protein LOC100748680 [Bombus impatiens] | Back alignment and taxonomy information |
|---|
| >gi|170045624|ref|XP_001850402.1| c-AMP-specific 3',5'-cyclic phosphodiesterase [Culex quinquefasciatus] gi|167868590|gb|EDS31973.1| c-AMP-specific 3',5'-cyclic phosphodiesterase [Culex quinquefasciatus] | Back alignment and taxonomy information |
|---|
| >gi|383863568|ref|XP_003707252.1| PREDICTED: uncharacterized protein LOC100877791 [Megachile rotundata] | Back alignment and taxonomy information |
|---|
| >gi|345491937|ref|XP_001599769.2| PREDICTED: hypothetical protein LOC100114896 [Nasonia vitripennis] | Back alignment and taxonomy information |
|---|
| >gi|158294334|ref|XP_315535.4| AGAP005536-PA [Anopheles gambiae str. PEST] gi|157015516|gb|EAA11823.5| AGAP005536-PA [Anopheles gambiae str. PEST] | Back alignment and taxonomy information |
|---|
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 249 | ||||||
| ZFIN|ZDB-GENE-031222-10 | 505 | pde7a "phosphodiesterase 7A" [ | 0.759 | 0.374 | 0.533 | 1.1e-53 | |
| UNIPROTKB|F1NVY7 | 424 | PDE7B "Uncharacterized protein | 0.722 | 0.424 | 0.554 | 8e-53 | |
| UNIPROTKB|E1BDB5 | 457 | LOC100849042 "Uncharacterized | 0.767 | 0.417 | 0.528 | 1.3e-52 | |
| UNIPROTKB|Q13946 | 482 | PDE7A "High affinity cAMP-spec | 0.767 | 0.396 | 0.528 | 1.3e-52 | |
| MGI|MGI:1202402 | 456 | Pde7a "phosphodiesterase 7A" [ | 0.767 | 0.418 | 0.528 | 2.1e-52 | |
| UNIPROTKB|F1RTC1 | 394 | PDE7A "Uncharacterized protein | 0.767 | 0.484 | 0.528 | 2.1e-52 | |
| UNIPROTKB|E2R487 | 457 | PDE7A "Uncharacterized protein | 0.767 | 0.417 | 0.523 | 2.7e-52 | |
| RGD|621016 | 446 | Pde7b "phosphodiesterase 7B" [ | 0.730 | 0.408 | 0.548 | 2.7e-52 | |
| UNIPROTKB|F1LN39 | 395 | Pde7b "Protein Pde7b" [Rattus | 0.730 | 0.460 | 0.548 | 2.7e-52 | |
| UNIPROTKB|F1LSY3 | 399 | Pde7b "Protein Pde7b" [Rattus | 0.730 | 0.456 | 0.548 | 2.7e-52 |
| ZFIN|ZDB-GENE-031222-10 pde7a "phosphodiesterase 7A" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 555 (200.4 bits), Expect = 1.1e-53, P = 1.1e-53
Identities = 103/193 (53%), Positives = 140/193 (72%)
Query: 14 VDNTSVLENHHWRSA---NTSVLENHHWRSAVGCLLESNVAEQLGSIRP-ELEQQISSLI 69
V+ +++ +H+ +A NTSVLENHHWRSAVG L E+ + L + +E+Q+ SLI
Sbjct: 276 VNQPFLIKTNHYLAALYRNTSVLENHHWRSAVGLLRETELFSHLPAEDSLSIERQLGSLI 335
Query: 70 LATDITRQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQ 129
LATDI+RQ E+L+RF+ +LD L+L A RHF+LQ+ALKCADI NPCRPW++SK+WS+
Sbjct: 336 LATDISRQNEYLSRFRTHLDENDLNLGNASHRHFVLQMALKCADICNPCRPWELSKQWSE 395
Query: 130 KVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLST 189
KV EEFF QGD E++L L ++ LCD + +I +Q GF +VV PLF EW RF DT+LS
Sbjct: 396 KVTEEFFHQGDIEKKLKLEISPLCDSEANTIASVQIGFMTYVVEPLFAEWARFSDTRLSQ 455
Query: 190 SMMGHLRGNQAKW 202
+M+GHL N+A W
Sbjct: 456 TMLGHLGLNKASW 468
|
|
| UNIPROTKB|F1NVY7 PDE7B "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|E1BDB5 LOC100849042 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|Q13946 PDE7A "High affinity cAMP-specific 3',5'-cyclic phosphodiesterase 7A" [Homo sapiens (taxid:9606)] | Back alignment and assigned GO terms |
|---|
| MGI|MGI:1202402 Pde7a "phosphodiesterase 7A" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1RTC1 PDE7A "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|E2R487 PDE7A "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
| RGD|621016 Pde7b "phosphodiesterase 7B" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1LN39 Pde7b "Protein Pde7b" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
| UNIPROTKB|F1LSY3 Pde7b "Protein Pde7b" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Prediction of Enzyme Commission (EC) Number
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 249 | |||
| pfam00233 | 237 | pfam00233, PDEase_I, 3'5'-cyclic nucleotide phosph | 1e-33 |
| >gnl|CDD|109297 pfam00233, PDEase_I, 3'5'-cyclic nucleotide phosphodiesterase | Back alignment and domain information |
|---|
Score = 121 bits (304), Expect = 1e-33
Identities = 52/184 (28%), Positives = 96/184 (52%), Gaps = 13/184 (7%)
Query: 16 NTSVLENHHWRSANTSVLENHHWRSAVGCLLESNVAEQLGSIRPELEQQISSLILATDIT 75
+ SVLENHH + +L++ + ++ + ++R + +ILATD++
Sbjct: 67 DESVLENHH-LAQAFKLLQDEECN-----IFQNLSKKDFQTLR----DLVIEMILATDMS 116
Query: 76 RQQEFLTRFKAYLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEF 135
+ L K ++ + + +L + + AD+SNP +PW + ++W++ + EEF
Sbjct: 117 LHFQKLKDLKTMVEQKKRLD--LDHKILLLSLLMHAADLSNPTKPWKLHRRWAELIMEEF 174
Query: 136 FRQGDYERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHL 195
F QGD ER+L LP + +CDR S +PK Q GF F+V P+F+ ++ K ++ +
Sbjct: 175 FDQGDLERELGLPPSPMCDRTSAYVPKSQVGFIDFIVEPIFKLLADVVE-KDIQPLLDTI 233
Query: 196 RGNQ 199
N+
Sbjct: 234 EDNR 237
|
Length = 237 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 249 | |||
| KOG3689|consensus | 707 | 100.0 | ||
| PF00233 | 237 | PDEase_I: 3'5'-cyclic nucleotide phosphodiesterase | 100.0 | |
| KOG3688|consensus | 554 | 100.0 | ||
| KOG1229|consensus | 775 | 100.0 |
| >KOG3689|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-54 Score=424.61 Aligned_cols=194 Identities=30% Similarity=0.605 Sum_probs=185.0
Q ss_pred ccchhhhH---HHHHHhCCCchhhccCHHHHHHHHhcC--ChhHhhc-cccHHHHHHHHHHHHhhcchhhHHHHHHHHHH
Q psy13496 14 VDNTSVLE---NHHWRSANTSVLENHHWRSAVGCLLES--NVAEQLG-SIRPELEQQISSLILATDITRQQEFLTRFKAY 87 (249)
Q Consensus 14 v~n~~~~~---~la~~Ynd~SVLEnhH~a~~~~iL~~~--~~~~~l~-~~~~~~rk~ii~~ILATDMs~Hf~~i~~~~~~ 87 (249)
|||.|++. .||.+|||.|||||||+++++.||+++ +|+.+++ .++..++++|+++|||||||+|++.++.|++.
T Consensus 478 tNN~f~iks~s~LA~lY~~~SvLE~HH~~~~~~lLqe~~~nIfsnLs~~~~~~~~~~i~~~ILATDla~h~~~~~~lk~~ 557 (707)
T KOG3689|consen 478 TNNSYLIKSNSPLAQLYNDSSVLENHHFAQAFKLLQEEGCNIFSNLSKKQYQQIRKLIIDAILATDLALHFKKRADLKEM 557 (707)
T ss_pred CCcHHHHhcCCHHHHHhCCccHHHHHHHHHHHHHHhccccchhhcCCHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 78999876 789999999999999999999999986 7888888 57899999999999999999999999999999
Q ss_pred hhc-CCCCCCChHHHHHHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHhhcchHHHhcCCCCCccCCCCCCCcccchhh
Q psy13496 88 LDS-GSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTG 166 (249)
Q Consensus 88 ~~~-~~~d~~~~~~r~lll~~li~~ADISn~~rp~~v~~~Wa~~l~eEF~~QGd~Ek~lglpvsp~~dR~~~~~~k~Qig 166 (249)
++. +.+++.+.+||.++++++||||||||+||||+++++|+++|++|||.|||+|+++|++|+|||||++..+|++|+|
T Consensus 558 v~~~~~~~~~~~~hr~lvl~mmmtacDLSn~TKpwei~~qwa~~I~~EFf~QGDeek~lg~~p~pmmDR~k~~vp~~Qvg 637 (707)
T KOG3689|consen 558 VETKGVYDLENYSHRILVLAMMMTACDLSNPTKPWEIQKQWAELIAEEFFDQGDEEKELGLEPSPMMDRDKASVPKLQVG 637 (707)
T ss_pred HhccCcccccchhHHHHHHHHHHHHhhccCCcCCccHHHHHHHHHHHHHHhcchHHHHcCCCCCcccccCcccCchhhhh
Confidence 988 7899999999999999999999999999999999999999999999999999999999999999999889999999
Q ss_pred hHhHhHHHHHHHHHHhcchhhhHHHHHHHHHHHHHHHhhhhhh
Q psy13496 167 FFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKFV 209 (249)
Q Consensus 167 Fi~~iv~Plf~~l~~~~p~~l~~~~l~~l~~N~~~W~~~~~~~ 209 (249)
||++||.|+|++|++++|+ .+++++.|+.|+.+|+++.+..
T Consensus 638 Fid~I~~Plyet~a~l~~~--~~pmld~l~~Nr~~w~~l~~~~ 678 (707)
T KOG3689|consen 638 FIDYICIPLYETWADLVPD--AQPMLDGLEDNREWWQSLIPES 678 (707)
T ss_pred HHHHHHHHHHHHHHHhccc--hhhHHHHHHHhHHHHHHhhhhh
Confidence 9999999999999999976 3789999999999999999876
|
|
| >PF00233 PDEase_I: 3'5'-cyclic nucleotide phosphodiesterase; InterPro: IPR002073 The cyclic nucleotide phosphodiesterases (PDE) comprise a group of enzymes that degrade the phosphodiester bond in the second messenger molecules cAMP and cGMP | Back alignment and domain information |
|---|
| >KOG3688|consensus | Back alignment and domain information |
|---|
| >KOG1229|consensus | Back alignment and domain information |
|---|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 249 | ||||
| 1zkl_A | 353 | Multiple Determinants For Inhibitor Selectivity Of | 1e-56 | ||
| 3g3n_A | 318 | Pde7a Catalytic Domain In Complex With 3-(2,6- Difl | 1e-56 | ||
| 3iad_A | 377 | Crystal Structure Of Human Phosphodiesterase 4d Wit | 4e-27 | ||
| 3g4g_A | 421 | Crystal Structure Of Human Phosphodiesterase 4d Wit | 9e-27 | ||
| 1tb7_A | 332 | Catalytic Domain Of Human Phosphodiesterase 4d In C | 9e-27 | ||
| 1xom_A | 349 | Catalytic Domain Of Human Phosphodiesterase 4d In C | 1e-26 | ||
| 1zkn_A | 334 | Structure Of Pde4d2-Ibmx Length = 334 | 1e-26 | ||
| 2qyn_A | 328 | Crystal Structure Of Pde4d2 In Complex With Inhibit | 1e-26 | ||
| 2pw3_A | 327 | Structure Of The Pde4d-Camp Complex Length = 327 | 1e-26 | ||
| 2fm0_A | 361 | Crystal Structure Of Pde4d In Complex With L-869298 | 2e-26 | ||
| 3g4i_A | 381 | Crystal Structure Of Human Phosphodiesterase 4d Wit | 2e-26 | ||
| 3sl5_A | 359 | Crystal Structure Of The Catalytic Domain Of Pde4d2 | 2e-26 | ||
| 1q9m_A | 360 | Three Dimensional Structures Of Pde4d In Complex Wi | 2e-26 | ||
| 1mkd_A | 328 | Crystal Structure Of Pde4d Catalytic Domain And Zar | 1e-25 | ||
| 3i8v_A | 354 | Crystal Structure Of Human Pde4a With 4-(3-butoxy-4 | 4e-25 | ||
| 3tvx_A | 338 | The Structure Of Pde4a With Pentoxifylline At 2.84a | 5e-25 | ||
| 2qyk_A | 335 | Crystal Structure Of Pde4a10 In Complex With Inhibi | 5e-25 | ||
| 3d3p_A | 353 | Crystal Structure Of Pde4b Catalytic Domain In Comp | 9e-25 | ||
| 1xlx_A | 398 | Catalytic Domain Of Human Phosphodiesterase 4b In C | 1e-24 | ||
| 3hmv_A | 378 | Catalytic Domain Of Human Phosphodiesterase 4b2b In | 1e-24 | ||
| 3kkt_A | 398 | Crystal Structure Of Human Pde4b With 5-[3-[(1s,2s, | 1e-24 | ||
| 1xlz_A | 398 | Catalytic Domain Of Human Phosphodiesterase 4b In C | 1e-24 | ||
| 1tb5_A | 381 | Catalytic Domain Of Human Phosphodiesterase 4b In C | 1e-24 | ||
| 1ro6_A | 378 | Crystal Structure Of Pde4b2b Complexed With Rolipra | 1e-24 | ||
| 1f0j_A | 377 | Catalytic Domain Of Human Phosphodiesterase 4b2b Le | 1e-24 | ||
| 3g45_A | 421 | Crystal Structure Of Human Phosphodiesterase 4b Wit | 4e-24 | ||
| 2qym_A | 358 | Crystal Structure Of Unliganded Pde4c2 Length = 358 | 4e-24 | ||
| 3o0j_A | 323 | Pde4b In Complex With Ligand An2898 Length = 323 | 5e-24 | ||
| 3ly2_A | 357 | Catalytic Domain Of Human Phosphodiesterase 4b In C | 5e-24 | ||
| 2qyl_A | 337 | Crystal Structure Of Pde4b2b In Complex With Inhibi | 5e-24 | ||
| 1xm6_A | 398 | Catalytic Domain Of Human Phosphodiesterase 4b In C | 2e-23 | ||
| 1xm4_A | 398 | Catalytic Domain Of Human Phosphodiesterase 4b In C | 2e-23 | ||
| 3ecm_A | 338 | Crystal Structure Of The Unliganded Pde8a Catalytic | 5e-22 | ||
| 3n3z_A | 326 | Crystal Structure Of Pde9a (E406a) Mutant In Comple | 8e-21 | ||
| 2yy2_A | 333 | Crystal Structure Of The Human Phosphodiesterase 9a | 8e-21 | ||
| 3dy8_A | 329 | Human Phosphodiesterase 9 In Complex With Product 5 | 9e-21 | ||
| 2hd1_A | 326 | Crystal Structure Of Pde9 In Complex With Ibmx Leng | 1e-20 | ||
| 3qi3_A | 533 | Crystal Structure Of Pde9a(Q453e) In Complex With I | 3e-20 | ||
| 1so2_A | 420 | Catalytic Domain Of Human Phosphodiesterase 3b In C | 8e-19 | ||
| 1taz_A | 365 | Catalytic Domain Of Human Phosphodiesterase 1b Leng | 1e-18 | ||
| 2r8q_A | 359 | Structure Of Lmjpdeb1 In Complex With Ibmx Length = | 2e-16 | ||
| 3hc8_A | 324 | Investigation Of Aminopyridiopyrazinones As Pde5 In | 6e-11 | ||
| 2chm_A | 326 | Crystal Structure Of N2 Substituted Pyrazolo Pyrimi | 6e-11 | ||
| 1t9s_A | 347 | Catalytic Domain Of Human Phosphodiesterase 5a In C | 1e-10 | ||
| 1xoz_A | 364 | Catalytic Domain Of Human Phosphodiesterase 5a In C | 1e-10 | ||
| 1rkp_A | 326 | Crystal Structure Of Pde5a1-Ibmx Length = 326 | 2e-10 | ||
| 3b2r_A | 330 | Crystal Structure Of Pde5a1 Catalytic Domain In Com | 3e-10 | ||
| 1udt_A | 324 | Crystal Structure Of Human Phosphodiesterase 5 Comp | 3e-10 | ||
| 2h40_A | 326 | Crystal Structure Of The Catalytic Domain Of Unliga | 3e-10 | ||
| 3shy_A | 347 | Crystal Structure Of The Pde5a1 Catalytic Domain In | 3e-10 | ||
| 3itm_A | 345 | Catalytic Domain Of Hpde2a Length = 345 | 4e-10 | ||
| 1z1l_A | 345 | The Crystal Structure Of The Phosphodiesterase 2a C | 4e-10 | ||
| 1t9r_A | 366 | Catalytic Domain Of Human Phosphodiesterase 5a Leng | 4e-10 | ||
| 3v93_A | 345 | Unliganded Structure Of Tcrpdec1 Catalytic Domain L | 4e-10 | ||
| 3bjc_A | 878 | Crystal Structure Of The Pde5a Catalytic Domain In | 5e-10 | ||
| 3jwq_A | 330 | Crystal Structure Of Chimeric Pde5/pde6 Catalytic D | 6e-10 | ||
| 4ddl_A | 338 | Pde10a Crystal Structure Complexed With Novel Inhib | 1e-09 | ||
| 2wey_A | 343 | Human Pde-Papaverine Complex Obtained By Ligand Soa | 1e-09 | ||
| 3ui7_A | 333 | Discovery Of Orally Active Pyrazoloquinoline As A P | 1e-09 | ||
| 2y0j_A | 340 | Triazoloquinazolines As A Novel Class Of Phosphodie | 1e-09 | ||
| 4ael_A | 344 | Pde10a In Complex With The Inhibitor Az5 Length = 3 | 1e-09 | ||
| 4heu_A | 318 | Crystal Structure Of Pde10a With A Biaryl Ether Inh | 1e-09 | ||
| 4dff_A | 352 | The Sar Development Of Dihydroimidazoisoquinoline D | 1e-09 | ||
| 2oun_A | 331 | Crystal Structure Of Pde10a2 In Complex With Amp Le | 1e-09 | ||
| 3sn7_A | 345 | Highly Potent, Selective, And Orally Active Phospho | 1e-09 | ||
| 2ouv_A | 331 | Crystal Structure Of Pde10a2 Mutant Of D564n Length | 1e-09 | ||
| 3uuo_A | 337 | The Discovery Of Potent, Selectivity, And Orally Bi | 1e-09 | ||
| 3ibj_A | 691 | X-Ray Structure Of Pde2a Length = 691 | 2e-09 | ||
| 3hqw_A | 376 | Discovery Of Novel Inhibitors Of Pde10a Length = 37 | 4e-09 | ||
| 3hqy_A | 380 | Discovery Of Novel Inhibitors Of Pde10a Length = 38 | 4e-09 | ||
| 2o8h_A | 362 | Crystal Structure Of The Catalytic Domain Of Rat Ph | 4e-09 | ||
| 3lxg_A | 308 | Crystal Structure Of Rat Phosphodiesterase 10a In C | 5e-09 | ||
| 2our_A | 331 | Crystal Structure Of Pde10a2 Mutant D674a In Comple | 1e-08 |
| >pdb|1ZKL|A Chain A, Multiple Determinants For Inhibitor Selectivity Of Cyclic Nucleotide Phosphodiesterases Length = 353 | Back alignment and structure |
|
| >pdb|3G3N|A Chain A, Pde7a Catalytic Domain In Complex With 3-(2,6- Difluorophenyl)-2-(Methylthio)quinazolin-4(3h)-One Length = 318 | Back alignment and structure |
| >pdb|3IAD|A Chain A, Crystal Structure Of Human Phosphodiesterase 4d With Bound Allosteric Modulator Length = 377 | Back alignment and structure |
| >pdb|3G4G|A Chain A, Crystal Structure Of Human Phosphodiesterase 4d With Regulatory Domain And D155871 Length = 421 | Back alignment and structure |
| >pdb|1TB7|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4d In Complex With Amp Length = 332 | Back alignment and structure |
| >pdb|1XOM|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4d In Complex With Cilomilast Length = 349 | Back alignment and structure |
| >pdb|1ZKN|A Chain A, Structure Of Pde4d2-Ibmx Length = 334 | Back alignment and structure |
| >pdb|2QYN|A Chain A, Crystal Structure Of Pde4d2 In Complex With Inhibitor Npv Length = 328 | Back alignment and structure |
| >pdb|2PW3|A Chain A, Structure Of The Pde4d-Camp Complex Length = 327 | Back alignment and structure |
| >pdb|2FM0|A Chain A, Crystal Structure Of Pde4d In Complex With L-869298 Length = 361 | Back alignment and structure |
| >pdb|3G4I|A Chain A, Crystal Structure Of Human Phosphodiesterase 4d With D155871 Length = 381 | Back alignment and structure |
| >pdb|3SL5|A Chain A, Crystal Structure Of The Catalytic Domain Of Pde4d2 Complexed With Compound 10d Length = 359 | Back alignment and structure |
| >pdb|1Q9M|A Chain A, Three Dimensional Structures Of Pde4d In Complex With Roliprams And Implication On Inhibitor Selectivity Length = 360 | Back alignment and structure |
| >pdb|1MKD|A Chain A, Crystal Structure Of Pde4d Catalytic Domain And Zardaverine Complex Length = 328 | Back alignment and structure |
| >pdb|3I8V|A Chain A, Crystal Structure Of Human Pde4a With 4-(3-butoxy-4-methoxyphenyl) Methyl-2-imidazolidone Length = 354 | Back alignment and structure |
| >pdb|3TVX|A Chain A, The Structure Of Pde4a With Pentoxifylline At 2.84a Resolution Length = 338 | Back alignment and structure |
| >pdb|2QYK|A Chain A, Crystal Structure Of Pde4a10 In Complex With Inhibitor Npv Length = 335 | Back alignment and structure |
| >pdb|3D3P|A Chain A, Crystal Structure Of Pde4b Catalytic Domain In Complex With A Pyrazolopyridine Inhibitor Length = 353 | Back alignment and structure |
| >pdb|1XLX|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex With Cilomilast Length = 398 | Back alignment and structure |
| >pdb|3HMV|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b2b In Complex Tetrahydrobenzothiophene Inhibitor Length = 378 | Back alignment and structure |
| >pdb|3KKT|A Chain A, Crystal Structure Of Human Pde4b With 5-[3-[(1s,2s,4r)- Bicyclo[2.2.1]hept-2-Yloxy]-4-Methoxyp Henyl]tetrahydro-2(1h)- Pyrimidinone Reveals Ordering Of The C-Terminal Helix Residues 502- 509. Length = 398 | Back alignment and structure |
| >pdb|1XLZ|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex With Filaminast Length = 398 | Back alignment and structure |
| >pdb|1TB5|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex With Amp Length = 381 | Back alignment and structure |
| >pdb|1RO6|A Chain A, Crystal Structure Of Pde4b2b Complexed With Rolipram (r & S) Length = 378 | Back alignment and structure |
| >pdb|1F0J|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b2b Length = 377 | Back alignment and structure |
| >pdb|3G45|A Chain A, Crystal Structure Of Human Phosphodiesterase 4b With Regulatory Domain And D155988 Length = 421 | Back alignment and structure |
| >pdb|2QYM|A Chain A, Crystal Structure Of Unliganded Pde4c2 Length = 358 | Back alignment and structure |
| >pdb|3O0J|A Chain A, Pde4b In Complex With Ligand An2898 Length = 323 | Back alignment and structure |
| >pdb|3LY2|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex Wi Coumarin-Based Inhibitor Length = 357 | Back alignment and structure |
| >pdb|2QYL|A Chain A, Crystal Structure Of Pde4b2b In Complex With Inhibitor Npv Length = 337 | Back alignment and structure |
| >pdb|1XM6|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex With (R)- Mesopram Length = 398 | Back alignment and structure |
| >pdb|1XM4|A Chain A, Catalytic Domain Of Human Phosphodiesterase 4b In Complex With Piclamilast Length = 398 | Back alignment and structure |
| >pdb|3ECM|A Chain A, Crystal Structure Of The Unliganded Pde8a Catalytic Domain Length = 338 | Back alignment and structure |
| >pdb|3N3Z|A Chain A, Crystal Structure Of Pde9a (E406a) Mutant In Complex With Ibmx Length = 326 | Back alignment and structure |
| >pdb|2YY2|A Chain A, Crystal Structure Of The Human Phosphodiesterase 9a Catalytic Domain Complexed With Ibmx Length = 333 | Back alignment and structure |
| >pdb|3DY8|A Chain A, Human Phosphodiesterase 9 In Complex With Product 5'-gmp (e+p Complex) Length = 329 | Back alignment and structure |
| >pdb|2HD1|A Chain A, Crystal Structure Of Pde9 In Complex With Ibmx Length = 326 | Back alignment and structure |
| >pdb|3QI3|A Chain A, Crystal Structure Of Pde9a(Q453e) In Complex With Inhibitor Bay73-6691 Length = 533 | Back alignment and structure |
| >pdb|1SO2|A Chain A, Catalytic Domain Of Human Phosphodiesterase 3b In Complex With A Dihydropyridazine Inhibitor Length = 420 | Back alignment and structure |
| >pdb|1TAZ|A Chain A, Catalytic Domain Of Human Phosphodiesterase 1b Length = 365 | Back alignment and structure |
| >pdb|2R8Q|A Chain A, Structure Of Lmjpdeb1 In Complex With Ibmx Length = 359 | Back alignment and structure |
| >pdb|3HC8|A Chain A, Investigation Of Aminopyridiopyrazinones As Pde5 Inhibitors: Evaluation Of Modifications To The Central Ring System. Length = 324 | Back alignment and structure |
| >pdb|2CHM|A Chain A, Crystal Structure Of N2 Substituted Pyrazolo Pyrimidinones- A Flipped Binding Mode In Pde5 Length = 326 | Back alignment and structure |
| >pdb|1T9S|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a In Complex With Gmp Length = 347 | Back alignment and structure |
| >pdb|1XOZ|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a In Complex With Tadalafil Length = 364 | Back alignment and structure |
| >pdb|1RKP|A Chain A, Crystal Structure Of Pde5a1-Ibmx Length = 326 | Back alignment and structure |
| >pdb|3B2R|A Chain A, Crystal Structure Of Pde5a1 Catalytic Domain In Complex With Vardenafil Length = 330 | Back alignment and structure |
| >pdb|1UDT|A Chain A, Crystal Structure Of Human Phosphodiesterase 5 Complexed With Sildenafil(Viagra) Length = 324 | Back alignment and structure |
| >pdb|2H40|A Chain A, Crystal Structure Of The Catalytic Domain Of Unliganded Pde5 Length = 326 | Back alignment and structure |
| >pdb|3SHY|A Chain A, Crystal Structure Of The Pde5a1 Catalytic Domain In Complex With Novel Inhibitors Length = 347 | Back alignment and structure |
| >pdb|3ITM|A Chain A, Catalytic Domain Of Hpde2a Length = 345 | Back alignment and structure |
| >pdb|1Z1L|A Chain A, The Crystal Structure Of The Phosphodiesterase 2a Catalytic Domain Length = 345 | Back alignment and structure |
| >pdb|1T9R|A Chain A, Catalytic Domain Of Human Phosphodiesterase 5a Length = 366 | Back alignment and structure |
| >pdb|3V93|A Chain A, Unliganded Structure Of Tcrpdec1 Catalytic Domain Length = 345 | Back alignment and structure |
| >pdb|3BJC|A Chain A, Crystal Structure Of The Pde5a Catalytic Domain In Complex With A Novel Inhibitor Length = 878 | Back alignment and structure |
| >pdb|3JWQ|A Chain A, Crystal Structure Of Chimeric Pde5/pde6 Catalytic Domain Complexed With Sildenafil Length = 330 | Back alignment and structure |
| >pdb|4DDL|A Chain A, Pde10a Crystal Structure Complexed With Novel Inhibitor Length = 338 | Back alignment and structure |
| >pdb|2WEY|A Chain A, Human Pde-Papaverine Complex Obtained By Ligand Soaking Of Cross-Linked Protein Crystals Length = 343 | Back alignment and structure |
| >pdb|3UI7|A Chain A, Discovery Of Orally Active Pyrazoloquinoline As A Potent Pde10 Inhibitor For The Management Of Schizophrenia Length = 333 | Back alignment and structure |
| >pdb|2Y0J|A Chain A, Triazoloquinazolines As A Novel Class Of Phosphodiesterase 10a (Pde10a) Inhibitors, Part 2, Lead-Optimisation. Length = 340 | Back alignment and structure |
| >pdb|4AEL|A Chain A, Pde10a In Complex With The Inhibitor Az5 Length = 344 | Back alignment and structure |
| >pdb|4HEU|A Chain A, Crystal Structure Of Pde10a With A Biaryl Ether Inhibitor ((1-(3-(4- ((1h-Benzo[d]imidazol-2-Yl)amino)phenoxy)pyridin-2- Yl)piperidin-4- Yl)methanol) Length = 318 | Back alignment and structure |
| >pdb|4DFF|A Chain A, The Sar Development Of Dihydroimidazoisoquinoline Derivatives As Phosphodiesterase 10a Inhibitors For The Treatment Of Schizophrenia Length = 352 | Back alignment and structure |
| >pdb|2OUN|A Chain A, Crystal Structure Of Pde10a2 In Complex With Amp Length = 331 | Back alignment and structure |
| >pdb|3SN7|A Chain A, Highly Potent, Selective, And Orally Active Phosphodiestarase 10a Inhibitors Length = 345 | Back alignment and structure |
| >pdb|2OUV|A Chain A, Crystal Structure Of Pde10a2 Mutant Of D564n Length = 331 | Back alignment and structure |
| >pdb|3UUO|A Chain A, The Discovery Of Potent, Selectivity, And Orally Bioavailable Pyrozoloquinolines As Pde10 Inhibitors For The Treatment Of Schizophrenia Length = 337 | Back alignment and structure |
| >pdb|3IBJ|A Chain A, X-Ray Structure Of Pde2a Length = 691 | Back alignment and structure |
| >pdb|3HQW|A Chain A, Discovery Of Novel Inhibitors Of Pde10a Length = 376 | Back alignment and structure |
| >pdb|3HQY|A Chain A, Discovery Of Novel Inhibitors Of Pde10a Length = 380 | Back alignment and structure |
| >pdb|2O8H|A Chain A, Crystal Structure Of The Catalytic Domain Of Rat Phosphodiesterase 10a Length = 362 | Back alignment and structure |
| >pdb|3LXG|A Chain A, Crystal Structure Of Rat Phosphodiesterase 10a In Complex Wi Web-3 Length = 308 | Back alignment and structure |
| >pdb|2OUR|A Chain A, Crystal Structure Of Pde10a2 Mutant D674a In Complex With Camp Length = 331 | Back alignment and structure |
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 249 | |||
| 1zkl_A | 353 | HCP1, TM22, high-affinity CAMP-specific 3',5'-cycl | 4e-73 | |
| 1y2k_A | 349 | DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi | 6e-67 | |
| 3v93_A | 345 | Cyclic nucleotide specific phosphodiesterase; para | 4e-64 | |
| 3g4g_A | 421 | DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi | 6e-64 | |
| 1so2_A | 420 | CGMP-inhibited 3',5'-cyclic phosphodiesterase B; P | 8e-64 | |
| 3ibj_A | 691 | CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE | 1e-63 | |
| 3hr1_A | 380 | CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod | 4e-63 | |
| 1f0j_A | 377 | PDE4B, phosphodiesterase 4B; PDE phosphodiesterase | 5e-63 | |
| 2our_A | 331 | CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod | 5e-63 | |
| 1taz_A | 365 | Calcium/calmodulin-dependent 3',5'-cyclic nucleot | 5e-62 | |
| 3dyn_A | 329 | High affinity CGMP-specific 3',5'-cyclic phosphod | 1e-61 | |
| 3itu_A | 345 | CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn- | 8e-61 | |
| 1tbf_A | 347 | CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 | 4e-60 | |
| 3ecm_A | 338 | High affinity CAMP-specific and IBMX-insensitive 3 | 7e-60 | |
| 3bjc_A | 878 | CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 | 8e-60 | |
| 3qi3_A | 533 | High affinity CGMP-specific 3',5'-cyclic phosphod | 2e-59 | |
| 2r8q_A | 359 | Class I phosphodiesterase PDEB1; leishimaniasis, p | 5e-57 | |
| 1vt4_I | 1221 | APAF-1 related killer DARK; drosophila apoptosome, | 3e-04 |
| >1zkl_A HCP1, TM22, high-affinity CAMP-specific 3',5'-cyclic phosphodiesterase 7A; PDE, hydrolase; HET: IBM; 1.67A {Homo sapiens} PDB: 3g3n_A* Length = 353 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 4e-73
Identities = 100/176 (56%), Positives = 130/176 (73%), Gaps = 1/176 (0%)
Query: 29 NTSVLENHHWRSAVGCLLESNVAEQL-GSIRPELEQQISSLILATDITRQQEFLTRFKAY 87
NTSVLENHHWRSAVG L ES + L R ++E QI +LILATDI+RQ E+L+ F+++
Sbjct: 148 NTSVLENHHWRSAVGLLRESGLFSHLPLESRQQMETQIGALILATDISRQNEYLSLFRSH 207
Query: 88 LDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNL 147
LD G L L RH +LQ+ALKCADI NPCR W++SK+WS+KV EEFF QGD E++ +L
Sbjct: 208 LDRGDLCLEDTRHRHLVLQMALKCADICNPCRTWELSKQWSEKVTEEFFHQGDIEKKYHL 267
Query: 148 PVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWE 203
V+ LCDRH+ SI IQ GF ++V PLF EW RF +T+LS +M+GH+ N+A W+
Sbjct: 268 GVSPLCDRHTESIANIQIGFMTYLVEPLFTEWARFSNTRLSQTMLGHVGLNKASWK 323
|
| >1y2k_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, pyrazole, hydrolase; HET: 7DE; 1.36A {Homo sapiens} SCOP: a.211.1.2 PDB: 1xon_A* 1xoq_A* 1xom_A* 1xor_A* 1y2c_A* 1y2d_A* 1y2e_A* 1y2b_A* 3iak_A* 3k4s_A* 1tbb_A* 1tb7_A* 3sl5_A* 3sl4_A* 2fm5_A* 3sl3_A* 2fm0_A* 3sl6_A* 3sl8_A* 1oyn_A* ... Length = 349 | Back alignment and structure |
|---|
| >3v93_A Cyclic nucleotide specific phosphodiesterase; parasite, phosphodiesterases,, hydrolase; 2.00A {Trypanosoma cruzi} PDB: 3v94_A* Length = 345 | Back alignment and structure |
|---|
| >3g4g_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, UCR2, alternative splicing, cytoplasm, cytoskeleton, hydrolase, membrane; HET: D71; 2.30A {Homo sapiens} PDB: 3g45_A* Length = 421 | Back alignment and structure |
|---|
| >1so2_A CGMP-inhibited 3',5'-cyclic phosphodiesterase B; PDE3B phosphodiesterase, hydrolase; HET: HG9 666; 2.40A {Homo sapiens} SCOP: a.211.1.2 PDB: 1soj_A* Length = 420 | Back alignment and structure |
|---|
| >3ibj_A CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE2A, GAF-domains, allosteric regulation hydrolase, membrane; 3.02A {Homo sapiens} Length = 691 | Back alignment and structure |
|---|
| >3hr1_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE 10A, PDE10 inhibitors, allosteric enzyme, alternative splicing; HET: PF9; 1.53A {Rattus norvegicus} PDB: 3hqy_A* 3hqz_A* 3hqw_A* Length = 380 | Back alignment and structure |
|---|
| >1f0j_A PDE4B, phosphodiesterase 4B; PDE phosphodiesterase, hydrolase; 1.77A {Homo sapiens} SCOP: a.211.1.2 PDB: 1ro6_A* 1ro9_A* 1ror_A* 3hmv_A* 1tb5_A* 1xm6_A* 1xlx_A* 1xm4_A* 1xlz_A* 1xmu_A* 1xmy_A* 1xn0_A* 1xos_A* 1xot_B* 1y2h_A* 1y2j_A* 3kkt_A* 3g4i_A* 3g4k_A* 3g4l_A* ... Length = 377 | Back alignment and structure |
|---|
| >2our_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE10, substrate specificity, hydrolase; HET: CMP; 1.45A {Homo sapiens} PDB: 2ous_A 2ouu_A* 3sn7_A* 3sni_A* 3snl_A* 4dff_A* 2wey_A* 2oun_A* 2oup_A 2ouq_A* 2ouv_A 2ouy_A* 4ael_A* 2y0j_A* 4ddl_A* 3uuo_A* 3ui7_A* 2o8h_A* 2ovv_A* 2ovy_A* ... Length = 331 | Back alignment and structure |
|---|
| >1taz_A Calcium/calmodulin-dependent 3',5'-cyclic nucleot phosphodiesterase 1B; PDE1B, hydrolase; HET: CME; 1.77A {Homo sapiens} SCOP: a.211.1.2 Length = 365 | Back alignment and structure |
|---|
| >3dyn_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; phophodiestrase, enzyme mechanism, hydrolase, manganes binding, phosphoprotein; HET: PCG IBM; 2.10A {Homo sapiens} SCOP: a.211.1.2 PDB: 3dyl_A* 3dy8_A* 3dyq_A* 3dys_A* 3jsi_A* 3jsw_A* 2yy2_A* 2hd1_A* 3k3e_A* 3k3h_A* 3n3z_A* Length = 329 | Back alignment and structure |
|---|
| >3itu_A CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn-binding, all-alpha-helical, alternative splicing, hydrolase, membrane, polymorphism; HET: IBM; 1.58A {Homo sapiens} PDB: 3itm_A* 1z1l_A Length = 345 | Back alignment and structure |
|---|
| >1tbf_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5A, hydrolase; HET: VIA; 1.30A {Homo sapiens} SCOP: a.211.1.2 PDB: 1t9s_A* 1xoz_A* 1xp0_A* 2chm_A* 3tge_A* 3tgg_A* 3hc8_A* 3hdz_A* 1t9r_A* 3sie_A* 3shy_A* 3shz_A* 3b2r_A* 2h44_A* 2h42_A* 2h40_A* 1rkp_A* 1udt_A* 1udu_A* 1uho_A* ... Length = 347 | Back alignment and structure |
|---|
| >3ecm_A High affinity CAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A...; phosphodiesterase 8A PDE8A inhibitor selectivity; 1.90A {Homo sapiens} PDB: 3ecn_A* Length = 338 | Back alignment and structure |
|---|
| >3bjc_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5, erectIle dysfunction, inhibitor design, allosteric enzyme, alternative splicing, CGMP binding; HET: WAN; 2.00A {Homo sapiens} SCOP: a.211.1.2 PDB: 3mf0_A 3lfv_A 2xss_A 2k31_A* Length = 878 | Back alignment and structure |
|---|
| >3qi3_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; mutation, glutamine switch, hydrolase-hydrolase inhibitor CO; HET: PDB; 2.30A {Homo sapiens} PDB: 3qi4_A* Length = 533 | Back alignment and structure |
|---|
| >2r8q_A Class I phosphodiesterase PDEB1; leishimaniasis, parasite inhibitor selectivity, CAMP phosphodiesterase, hydrolase; HET: IBM; 1.50A {Leishmania major} Length = 359 | Back alignment and structure |
|---|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 249 | |||
| 3dyn_A | 329 | High affinity CGMP-specific 3',5'-cyclic phosphod | 100.0 | |
| 3itu_A | 345 | CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn- | 100.0 | |
| 3v93_A | 345 | Cyclic nucleotide specific phosphodiesterase; para | 100.0 | |
| 2our_A | 331 | CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod | 100.0 | |
| 3hr1_A | 380 | CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphod | 100.0 | |
| 1zkl_A | 353 | HCP1, TM22, high-affinity CAMP-specific 3',5'-cycl | 100.0 | |
| 1f0j_A | 377 | PDE4B, phosphodiesterase 4B; PDE phosphodiesterase | 100.0 | |
| 3g4g_A | 421 | DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi | 100.0 | |
| 3ecm_A | 338 | High affinity CAMP-specific and IBMX-insensitive 3 | 100.0 | |
| 1y2k_A | 349 | DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodi | 100.0 | |
| 1tbf_A | 347 | CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 | 100.0 | |
| 3qi3_A | 533 | High affinity CGMP-specific 3',5'-cyclic phosphod | 100.0 | |
| 2r8q_A | 359 | Class I phosphodiesterase PDEB1; leishimaniasis, p | 100.0 | |
| 1taz_A | 365 | Calcium/calmodulin-dependent 3',5'-cyclic nucleot | 100.0 | |
| 1so2_A | 420 | CGMP-inhibited 3',5'-cyclic phosphodiesterase B; P | 100.0 | |
| 3ibj_A | 691 | CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE | 100.0 | |
| 3bjc_A | 878 | CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5 | 100.0 |
| >3dyn_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; phophodiestrase, enzyme mechanism, hydrolase, manganes binding, phosphoprotein; HET: PCG IBM; 2.10A {Homo sapiens} SCOP: a.211.1.2 PDB: 3dyl_A* 3dy8_A* 3dyq_A* 3dys_A* 3jsi_A* 3jsw_A* 2yy2_A* 2hd1_A* 3k3e_A* 3k3h_A* 4gh6_A* 3n3z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-57 Score=415.02 Aligned_cols=192 Identities=32% Similarity=0.527 Sum_probs=178.4
Q ss_pred ccchhhhH---HHHHHhCCCchhhccCHHHHHHHHhcC--ChhHhhc-cccHHHHHHHHHHHHhhcchhhHHHHHHHHHH
Q psy13496 14 VDNTSVLE---NHHWRSANTSVLENHHWRSAVGCLLES--NVAEQLG-SIRPELEQQISSLILATDITRQQEFLTRFKAY 87 (249)
Q Consensus 14 v~n~~~~~---~la~~Ynd~SVLEnhH~a~~~~iL~~~--~~~~~l~-~~~~~~rk~ii~~ILATDMs~Hf~~i~~~~~~ 87 (249)
+||.|++. .||++|||+|||||||++++|.||+++ |++.+++ ..+..+|++||++||||||++||+++++|++.
T Consensus 122 ~nN~fli~t~s~LA~lYnd~SvLEnhH~a~~~~lL~~~~~nif~~l~~~~~~~~r~~ii~~ILATDm~~Hf~~l~~~~~~ 201 (329)
T 3dyn_A 122 YNNTYQINARTELAVRYNDISPLENHHCAVAFQILAEPECNIFSNIPPDGFKQIRQGMITLILATDMARHAEIMDSFKEK 201 (329)
T ss_dssp SCHHHHHHHTCHHHHHHTTSSHHHHHHHHHHHHHHTSGGGCTTTTSCHHHHHHHHHHHHHHHHHTCGGGHHHHHHHHHHH
T ss_pred CCCHHHHHhCCHHHHHcCCCcHhHHHHHHHHHHHHhcccchhccCCCHHHHHHHHHHHHHHHHHhhHHHHHHHHHHHHHH
Confidence 68888876 789999999999999999999999854 6777776 46788999999999999999999999999998
Q ss_pred hhcCCCCCCChHHHHHHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHhhcchHHHhcCCCCCccCCCCCCCcccchhhh
Q psy13496 88 LDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKIQTGF 167 (249)
Q Consensus 88 ~~~~~~d~~~~~~r~lll~~li~~ADISn~~rp~~v~~~Wa~~l~eEF~~QGd~Ek~lglpvsp~~dR~~~~~~k~QigF 167 (249)
++ .+|+.++++|.++++++||||||||++|||+++++|+.++++|||.|||+|+++|+|++|+|||++..+|++|+||
T Consensus 202 ~~--~~~~~~~~~~~ll~~~lik~ADiSn~~rp~~v~~~W~~~l~eEFf~QgD~Ek~~glp~sp~~DR~~~~~~k~QigF 279 (329)
T 3dyn_A 202 ME--NFDYSNEEHMTLLKMILIKCCDISNEVRPMEVAEPWVDCLLEEYFMQSDREKSEGLPVAPFMDRDKVTKATAQIGF 279 (329)
T ss_dssp HT--TCCTTCHHHHHHHHHHHHHHHHTCGGGSCHHHHHHHHHHHHHHHHHHHHHHHHHTCCCCGGGCTTTCCHHHHHHHH
T ss_pred Hh--hcccCCHHHHHHHHHHHHHHHhcccccCChHHHHHHHHHHHHHHHHhhhHHHhcCCCCCCCCCccccchhHHHHHH
Confidence 75 5788899999999999999999999999999999999999999999999999999999999999998999999999
Q ss_pred HhHhHHHHHHHHHHhcchhhhHHHHHHHHHHHHHHHhhhhh
Q psy13496 168 FKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKF 208 (249)
Q Consensus 168 i~~iv~Plf~~l~~~~p~~l~~~~l~~l~~N~~~W~~~~~~ 208 (249)
|++||.|+|+++++++|+ +.++++++|++|+++|+++.+.
T Consensus 280 i~~iv~Pl~~~l~~~~P~-~~~~~l~~L~~Nr~~w~~l~~~ 319 (329)
T 3dyn_A 280 IKFVLIPMFETVTKLFPM-VEEIMLQPLWESRDRYEELKRI 319 (329)
T ss_dssp HHHTHHHHHHHHHHHCTH-HHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHCHh-hHHHHHHHHHHHHHHHHHHHHH
Confidence 999999999999999997 6557999999999999998764
|
| >3itu_A CGMP-dependent 3',5'-cyclic phosphodiesterase; Zn-binding, all-alpha-helical, alternative splicing, hydrolase, membrane, polymorphism; HET: IBM; 1.58A {Homo sapiens} PDB: 3itm_A* 1z1l_A | Back alignment and structure |
|---|
| >3v93_A Cyclic nucleotide specific phosphodiesterase; parasite, phosphodiesterases,, hydrolase; 2.00A {Trypanosoma cruzi} PDB: 3v94_A* | Back alignment and structure |
|---|
| >2our_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE10, substrate specificity, hydrolase; HET: CMP; 1.45A {Homo sapiens} PDB: 2ous_A 2ouu_A* 3sn7_A* 3sni_A* 3snl_A* 4dff_A* 2wey_A* 2oun_A* 2oup_A 2ouq_A* 2ouv_A 2ouy_A* 4ael_A* 2y0j_A* 4ddl_A* 3uuo_A* 3ui7_A* 2o8h_A* 2ovv_A* 2ovy_A* ... | Back alignment and structure |
|---|
| >3hr1_A CAMP and CAMP-inhibited CGMP 3',5'-cyclic phosphodiesterase 10A; PDE 10A, PDE10 inhibitors, allosteric enzyme, alternative splicing; HET: PF9; 1.53A {Rattus norvegicus} PDB: 3hqy_A* 3hqz_A* 3hqw_A* | Back alignment and structure |
|---|
| >1zkl_A HCP1, TM22, high-affinity CAMP-specific 3',5'-cyclic phosphodiesterase 7A; PDE, hydrolase; HET: IBM; 1.67A {Homo sapiens} PDB: 3g3n_A* | Back alignment and structure |
|---|
| >1f0j_A PDE4B, phosphodiesterase 4B; PDE phosphodiesterase, hydrolase; 1.77A {Homo sapiens} SCOP: a.211.1.2 PDB: 1ro6_A* 1ro9_A* 1ror_A* 3hmv_A* 1tb5_A* 1xm6_A* 1xlx_A* 1xm4_A* 1xlz_A* 1xmu_A* 1xmy_A* 1xn0_A* 1xos_A* 1xot_B* 1y2h_A* 1y2j_A* 3kkt_A* 3g4i_A* 3g4k_A* 3g4l_A* ... | Back alignment and structure |
|---|
| >3g4g_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, UCR2, alternative splicing, cytoplasm, cytoskeleton, hydrolase, membrane; HET: D71; 2.30A {Homo sapiens} PDB: 3g45_A* | Back alignment and structure |
|---|
| >3ecm_A High affinity CAMP-specific and IBMX-insensitive 3',5'-cyclic phosphodiesterase 8A...; phosphodiesterase 8A PDE8A inhibitor selectivity; 1.90A {Homo sapiens} SCOP: a.211.1.0 PDB: 3ecn_A* | Back alignment and structure |
|---|
| >1y2k_A DPDE3, PDE43, CAMP-specific 3',5'-cyclic phosphodiesterase 4D; PDE4D, pyrazole, hydrolase; HET: 7DE; 1.36A {Homo sapiens} SCOP: a.211.1.2 PDB: 1xon_A* 1xoq_A* 1xom_A* 1xor_A* 1y2c_A* 1y2d_A* 1y2e_A* 1y2b_A* 3iak_A* 3k4s_A* 1tbb_A* 1tb7_A* 3sl5_A* 3sl4_A* 2fm5_A* 3sl3_A* 2fm0_A* 3sl6_A* 3sl8_A* 1oyn_A* ... | Back alignment and structure |
|---|
| >1tbf_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5A, hydrolase; HET: VIA; 1.30A {Homo sapiens} SCOP: a.211.1.2 PDB: 1t9s_A* 1xoz_A* 1xp0_A* 2chm_A* 3tge_A* 3tgg_A* 3hc8_A* 3hdz_A* 1t9r_A* 3sie_A* 3shy_A* 3shz_A* 3b2r_A* 2h44_A* 2h42_A* 2h40_A* 1rkp_A* 1udt_A* 1udu_A* 1uho_A* ... | Back alignment and structure |
|---|
| >3qi3_A High affinity CGMP-specific 3',5'-cyclic phosphod 9A; mutation, glutamine switch, hydrolase-hydrolase inhibitor CO; HET: PDB; 2.30A {Homo sapiens} PDB: 3qi4_A* | Back alignment and structure |
|---|
| >2r8q_A Class I phosphodiesterase PDEB1; leishimaniasis, parasite inhibitor selectivity, CAMP phosphodiesterase, hydrolase; HET: IBM; 1.50A {Leishmania major} | Back alignment and structure |
|---|
| >1taz_A Calcium/calmodulin-dependent 3',5'-cyclic nucleot phosphodiesterase 1B; PDE1B, hydrolase; HET: CME; 1.77A {Homo sapiens} SCOP: a.211.1.2 | Back alignment and structure |
|---|
| >1so2_A CGMP-inhibited 3',5'-cyclic phosphodiesterase B; PDE3B phosphodiesterase, hydrolase; HET: HG9 666; 2.40A {Homo sapiens} SCOP: a.211.1.2 PDB: 1soj_A* | Back alignment and structure |
|---|
| >3ibj_A CGMP-dependent 3',5'-cyclic phosphodiesterase; PDE2A, GAF-domains, allosteric regulation hydrolase, membrane; 3.02A {Homo sapiens} | Back alignment and structure |
|---|
| >3bjc_A CGMP-specific 3',5'-cyclic phosphodiesterase; PDE5, erectIle dysfunction, inhibitor design, allosteric enzyme, alternative splicing, CGMP binding; HET: WAN; 2.00A {Homo sapiens} SCOP: a.211.1.2 PDB: 3mf0_A 3lfv_A 2xss_A 2k31_A* | Back alignment and structure |
|---|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 249 | ||||
| d1so2a_ | 415 | a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phospho | 2e-49 | |
| d1y2ka1 | 326 | a.211.1.2 (A:86-411) Catalytic domain of cyclic nu | 2e-45 | |
| d1tbfa_ | 326 | a.211.1.2 (A:) cGMP-specific 3',5'-cyclic phosphod | 4e-45 | |
| d3dy8a1 | 324 | a.211.1.2 (A:182-505) High-affinity cGMP-specific | 6e-45 | |
| d1taza_ | 357 | a.211.1.2 (A:) Catalytic domain of cyclic nucleoti | 4e-43 |
| >d1so2a_ a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b {Human (Homo sapiens) [TaxId: 9606]} Length = 415 | Back information, alignment and structure |
|---|
class: All alpha proteins fold: HD-domain/PDEase-like superfamily: HD-domain/PDEase-like family: PDEase domain: cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b species: Human (Homo sapiens) [TaxId: 9606]
Score = 165 bits (418), Expect = 2e-49
Identities = 59/229 (25%), Positives = 91/229 (39%), Gaps = 19/229 (8%)
Query: 29 NTSVLENHHWRSAVGCLLESNVAEQLGSIRPE----LEQQISSLILATDITRQQEFLTRF 84
+ SVLENHH SA L L + + ILATD+ + +FL F
Sbjct: 188 DRSVLENHHAASAWNLYLSRPEYNFLLHLDHVEFKRFRFLVIEAILATDLKKHFDFLAEF 247
Query: 85 KA---YLDSGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDY 141
A ++S ++ S DR + Q+ +K ADI+ P + D+ KW++ + EF+ QGD
Sbjct: 248 NAKANDVNSNGIEWSNENDRLLVCQVCIKLADINGPAKVRDLHLKWTEGIVNEFYEQGDE 307
Query: 142 ERQLNLPVTSLCDRHSTSIPKIQTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAK 201
E L LP++ DR S + K+Q F +V PL + L + N +
Sbjct: 308 EANLGLPISPFMDRSSPQLAKLQESFITHIVGPLCNSYDAAGL--LPGQWLEAEEDNDTE 365
Query: 202 WEGFFKFVVSPLFEEWHRFLDT----------KLSTSMMGHLRGNQAKW 240
+E ++ +M HL N W
Sbjct: 366 SGDDEDGEELDTEDEEMENNLNPKPPRRKSRRRIFCQLMHHLTENHKIW 414
|
| >d1y2ka1 a.211.1.2 (A:86-411) Catalytic domain of cyclic nucleotide phosphodiesterase pde4d {Human (Homo sapiens) [TaxId: 9606]} Length = 326 | Back information, alignment and structure |
|---|
| >d1tbfa_ a.211.1.2 (A:) cGMP-specific 3',5'-cyclic phosphodiesterase pde5a1-Ibmx {Human (Homo sapiens) [TaxId: 9606]} Length = 326 | Back information, alignment and structure |
|---|
| >d3dy8a1 a.211.1.2 (A:182-505) High-affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, PDE9A {Human (Homo sapiens) [TaxId: 9606]} Length = 324 | Back information, alignment and structure |
|---|
| >d1taza_ a.211.1.2 (A:) Catalytic domain of cyclic nucleotide phosphodiesterase 1b, PDE1B {Human (Homo sapiens) [TaxId: 9606]} Length = 357 | Back information, alignment and structure |
|---|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 249 | |||
| d1so2a_ | 415 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B, p | 100.0 | |
| d3dy8a1 | 324 | High-affinity cGMP-specific 3',5'-cyclic phosphodi | 100.0 | |
| d1y2ka1 | 326 | Catalytic domain of cyclic nucleotide phosphodiest | 100.0 | |
| d1tbfa_ | 326 | cGMP-specific 3',5'-cyclic phosphodiesterase pde5a | 100.0 | |
| d1taza_ | 357 | Catalytic domain of cyclic nucleotide phosphodiest | 100.0 |
| >d1so2a_ a.211.1.2 (A:) cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: All alpha proteins fold: HD-domain/PDEase-like superfamily: HD-domain/PDEase-like family: PDEase domain: cGMP-inhibited 3',5'-cyclic phosphodiesterase B, pde3b species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-55 Score=413.03 Aligned_cols=226 Identities=27% Similarity=0.384 Sum_probs=177.2
Q ss_pred ccchhhhH---HHHHHhCCCchhhccCHHHHHHHHhcC---ChhHhhc-cccHHHHHHHHHHHHhhcchhhHHHHHHHHH
Q psy13496 14 VDNTSVLE---NHHWRSANTSVLENHHWRSAVGCLLES---NVAEQLG-SIRPELEQQISSLILATDITRQQEFLTRFKA 86 (249)
Q Consensus 14 v~n~~~~~---~la~~Ynd~SVLEnhH~a~~~~iL~~~---~~~~~l~-~~~~~~rk~ii~~ILATDMs~Hf~~i~~~~~ 86 (249)
|+|.|++. +||++|||+|||||||++++|+++.+. +++.+++ ..+..+|++||++||||||++||+++++|+.
T Consensus 170 ~nN~Flv~t~~pLA~lYnd~SVLEnhH~a~a~~lll~~~~~nil~~l~~~e~~~~r~lii~~ILATDm~~Hf~~l~~f~~ 249 (415)
T d1so2a_ 170 RTNAFLVATNAPQAVLYNDRSVLENHHAASAWNLYLSRPEYNFLLHLDHVEFKRFRFLVIEAILATDLKKHFDFLAEFNA 249 (415)
T ss_dssp CCHHHHHHTTCHHHHHTTTSSHHHHHHHHHHHHHHHTCGGGCTTTTSCHHHHHHHHHHHHHHHHTTCGGGHHHHHHHHHH
T ss_pred ccHHHHHHcCCHHHHHhCCCCHHHHHHHHHHHHHHhcCcccchhhcCCHHHHHHHHHHHHHHHHccchhhHHHHHHHHHH
Confidence 89999987 689999999999999999999985433 5666666 4578899999999999999999999999998
Q ss_pred Hhh---cCCCCCCChHHHHHHHHHHHhhccCCCCCCChHHHHHHHHHHHHHHhhcchHHHhcCCCCCccCCCCCCCcccc
Q psy13496 87 YLD---SGSLDLSKAEDRHFILQIALKCADISNPCRPWDVSKKWSQKVCEEFFRQGDYERQLNLPVTSLCDRHSTSIPKI 163 (249)
Q Consensus 87 ~~~---~~~~d~~~~~~r~lll~~li~~ADISn~~rp~~v~~~Wa~~l~eEF~~QGd~Ek~lglpvsp~~dR~~~~~~k~ 163 (249)
+.+ .+++++.+++||.++++++|||||||||+|||+++.+|+.+|++|||.|||+|+++|+|++|+|||++.++|++
T Consensus 250 ~~~~~~~~~~~~~~~~~r~lv~~~lik~ADIs~~~rp~~v~~~W~~~l~~EF~~QGd~E~~lglp~sp~~DR~~~~~~k~ 329 (415)
T d1so2a_ 250 KANDVNSNGIEWSNENDRLLVCQVCIKLADINGPAKVRDLHLKWTEGIVNEFYEQGDEEANLGLPISPFMDRSSPQLAKL 329 (415)
T ss_dssp HHTSSSCCCCCTTCHHHHHHHHHHHHHHHHTCGGGSCHHHHHHHHHHHHHHHHHHHHHHHHTTCCCCTTCCTTSCCHHHH
T ss_pred HHHhhccCCcCCCCHHHHHHHHHHHHHHHhccCcccChHHHHHHHHHHHHHHHHHHHHHHhcCCCCCcccCcccccchHH
Confidence 864 46788999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hhhhHhHhHHHHHHHHHHhcchhhhHHHHHHHHHHHHHHHhhhhhhcCcch-hhh---------Hhhhccccchhhhccc
Q psy13496 164 QTGFFKFVVSPLFEEWHRFLDTKLSTSMMGHLRGNQAKWEGFFKFVVSPLF-EEW---------HRFLDTKLSTSMMGHL 233 (249)
Q Consensus 164 QigFi~~iv~Plf~~l~~~~p~~l~~~~l~~l~~N~~~W~~~~~~~~~~~~-~~~---------~~~~~~~~~~~~~~~~ 233 (249)
|+|||++||+|||++++.+.+. . .++++++.+|+.+|++..+.+..+.. ++. .+..+++.-...++++
T Consensus 330 QigFi~~iv~PLf~~l~~a~~~-~-~~~~~~~~~n~~~w~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 407 (415)
T d1so2a_ 330 QESFITHIVGPLCNSYDAAGLL-P-GQWLEAEEDNDTESGDDEDGEELDTEDEEMENNLNPKPPRRKSRRRIFCQLMHHL 407 (415)
T ss_dssp HHHHHHHTHHHHHHHHHHTTCS-C-CEECC-------------------------------------CCSSEECHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHhhc-c-HHHHHHHHHHHHHHHHhHhhhhccchhhccccccccCCcchhhHHHHhhHHHHHH
Confidence 9999999999999999886543 1 35788999999999876554322211 111 1123444555788899
Q ss_pred cccccccc
Q psy13496 234 RGNQAKWE 241 (249)
Q Consensus 234 ~~~~~~~~ 241 (249)
.-|...|+
T Consensus 408 ~en~~~w~ 415 (415)
T d1so2a_ 408 TENHKIWK 415 (415)
T ss_dssp HHHHHHHC
T ss_pred HhhhhhcC
Confidence 99999996
|
| >d3dy8a1 a.211.1.2 (A:182-505) High-affinity cGMP-specific 3',5'-cyclic phosphodiesterase 9A, PDE9A {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1y2ka1 a.211.1.2 (A:86-411) Catalytic domain of cyclic nucleotide phosphodiesterase pde4d {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1tbfa_ a.211.1.2 (A:) cGMP-specific 3',5'-cyclic phosphodiesterase pde5a1-Ibmx {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
| >d1taza_ a.211.1.2 (A:) Catalytic domain of cyclic nucleotide phosphodiesterase 1b, PDE1B {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|